immunoglobulins - PiNSA Members

UK Clinical Guidelines For Immunoglobulin Use 2011

PiNSA — Mon, 06 Mar 2023 12:26:45 +0000

Report any adverse reactions to IG products

PiNSA — Fri, 19 Jul 2019 13:54:41 +0000

To all our members It is vital that you, or your treating doctor/nurse use this form to notify SAHPRA of any adverse reaction that you might have from using IG products. This information is vital for several reasons including the following: You can report an adverse event even if you are not certain that it...

The post Report any adverse reactions to IG products first appeared on PiNSA Members.

Prevention of Infections during Primary Immunodeficiency 2014

PiNSA — Sat, 15 Nov 2014 13:07:10 +0000

PINSA POSITION STATEMENT ON ACCESS TO IMMUNOGLOBULIN THERAPIES FOR PATIENTS LIVING WITH A PRIMARY IMMUNODEFICIENCY

PiNSA — Mon, 29 Sep 2014 18:48:52 +0000

July 2014 This PiNSA statement supports international calls to ensure access to the best suited immunoglobulin (IG) replacement therapy, as prescribed by physicians for patients living with a primary immunodeficiency (PID)[1] that requires IG replacement therapy. It is estimated that there are between 20,000- 40,000 South Africans living with PID, of whom 99% remain undiagnosed....

The post PINSA POSITION STATEMENT ON ACCESS TO IMMUNOGLOBULIN THERAPIES FOR PATIENTS LIVING WITH A PRIMARY IMMUNODEFICIENCY first appeared on PiNSA Members.

IPOPI POSITION STATEMENT Access to Immunoglobulin Therapies for patients living with a Primary Immunodeficiency

PiNSA — Mon, 29 Sep 2014 18:45:13 +0000

8 May 2012 This statement is intended to provide a summary of IPOPI’s position with regards to the importance of ensuring access for patients living with a primary immunodeficiency (PID) to the best suited immunoglobulin (IG) replacement therapy, as selected and prescribed by their physician. IPOPI is concerned by recent developments in several countries that...

The post IPOPI POSITION STATEMENT Access to Immunoglobulin Therapies for patients living with a Primary Immunodeficiency first appeared on PiNSA Members.

Immunoglobulin therapy

PiNSA — Tue, 09 Sep 2014 13:17:14 +0000

If you have any other queries about immunoglobulin therapy you would like answers to, please contact us. What is immunoglobulin replacement therapy? Immunoglobulin (IG) replacement therapy is a blood-based treatment. The immunoglobulin contains antibodies which will help fight infection. You have been recommended this treatment because your doctors have found that your immune system (or your...

The post Immunoglobulin therapy first appeared on PiNSA Members.